July 22, 2016

Teva Pharmaceuticals has added Sumatriptan Injection, USP (autoinjector) to its line of generic products. 

July 20, 2016

The finding points to a potential gap in competition that has allowed prices for some generics to climb.

July 20, 2016

The pilot program would allow the Department of Defense to access lower pricing for prescriptions dispensed at community pharmacies.

July 20, 2016

"Working together with NCPA staff, the Innovation Center will help better position independent community pharmacies to be part of and benefit from broader health care changes," suggested Doug Hoey, NCPA CEO.

July 19, 2016
Ajanta’s Axert generics will be available in 6.25- and 12.5-mg dosage strength. 
July 19, 2016

The drug had U.S. sales of about $15.7 million for the 12 months ended May 2016, according to IMS Health. 

July 18, 2016

ANI’s is the first generic of the Nilandron, which is indicated to treat metastatic prostate cancer in combination with surgical castration. 

July 18, 2016

The drug had U.S. sales of about $306.7 million for the 12 months ended May 2016, according to IMS Health. 

July 15, 2016

In addition to leveraging a pipeline of complex generics across its markets while focusing on OTC, Dr. Reddy's chairman K Satish Reddy said the branded generics would be one of the ways the company drives growth in the coming years.

July 13, 2016
Reuters is reporting that the FDA’s Arthritis Advisory Board has unanimously recommended Amgen’s biosimilar of AbbVie’s Humira, ABP 501. The panel said that the drug was similar in safety and effectiveness to Humira for rheumatoid arthritis and plaque psoriasis, and it recommended that the biosimilar should also be approved for Crohn’s disease in adults and ulcerative colitis. (Reuters)
July 12, 2016

The agency has acted on 90% of the generic drug and prior approval supplement applications pending as of Oct. 1, 2012 — which puts it more than a year ahead of its final deadline of Sept. 30, 2017. 

July 12, 2016

The move is aimed at Nichi-Iko becoming one of the top 10 global generics leaders, and the companies said acquiring Sagent will boost Nichi-Iko’s ability to commercialize its biosimilar pipeline and increase its presence in injectables.

July 6, 2016

Mylan’s fenofibrate tablets will be available in 40- and 120-mg dosage strengths. 

July 5, 2016

For the quarter, the company saw revenues of $723.6 million — a 1.6% rise over the same quarter last year that it attributes to overall market growth and the expansion of its franchised store network.

July 1, 2016
NACDS and NCPA urged the Senate committee to adopt the House’s position in its version of the National Defense Authorization Act , which does not include provisions that would increase TRICARE copays, arguing that higher copays can have detrimental effects on patient health and federal spending. 
June 30, 2016

Toohey is the former president and CEO of the Semiconductor Industry Association, where he oversaw that industry’s federal advocacy, international trade and technology programs, as well as a veteran of PhRMA’s advocacy team. 

June 29, 2016

The Consumer Healthcare Products Association has published a case study regarding efforts to curb teen abuse of over-the-counter cough medicine containing dextromethorphan. 

June 28, 2016

Health care is local. But the back-end service that enables the delivery of that localized healthcare experience has become increasingly global both in size and scope.

June 28, 2016

Prasco Laboratories has entered into agreements with Teva and Shire to acquire the rights to distribute the generic version of Adderall XR Extended Release Capsules.  

June 27, 2016

Mylan announced Monday that it has launched Dutasteride Capsules, 0.5 mg, the generic version of GlaxoSmithKline's Avodart Capsules, in the U.S.

June 27, 2016

Pharmasave announced that its pharmacists have been trained to be leaders in providing medication therapy management programs.

June 27, 2016

The Price Relief, Innovation and Competition for Essential Drugs (PRICED) Act would amend the Public Health Service act to change the exclusivity period from 12 years to seven years. 

June 24, 2016

The drug is indicated to treat mild to moderate active and in remission Crohn’s disease in the ileum and/or ascending colon. 

June 23, 2016

Specifically, CMS' proposed guidance would standardize the reporting by PDP sponsors of price concessions received from, and incentive payments made to, participating network pharmacies.